248 related articles for article (PubMed ID: 9417352)
1. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
Diekamp U; Kamutzky K; Windel CD
Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
[TBL] [Abstract][Full Text] [Related]
2. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
3. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
4. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
5. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
Wang JE
J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL
Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of hepatitis C virus in blood donors and comparison of 4 different anti-HCV differentiation tests].
Hennig H; Haase D; Kirchner H
Beitr Infusionsther Transfusionsmed; 1996; 33():231-4. PubMed ID: 8974699
[TBL] [Abstract][Full Text] [Related]
9. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
10. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
[TBL] [Abstract][Full Text] [Related]
12. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
13. Recent Canadian experience with targeted hepatitis C virus lookback.
Goldman M; Patterson L; Long A
Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
[TBL] [Abstract][Full Text] [Related]
14. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
15. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
[TBL] [Abstract][Full Text] [Related]
16. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.
van de Laar TJ; Koppelman MH; van der Bij AK; Zaaijer HL; Cuijpers HT; van der Poel CL; Coutinho RA; Bruisten SM
Transfusion; 2006 Oct; 46(10):1719-28. PubMed ID: 17002628
[TBL] [Abstract][Full Text] [Related]
17. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].
Schottstedt V; Tuma W; Bünger G; Lakenberg P
Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342
[TBL] [Abstract][Full Text] [Related]
18. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
